Immunogenic shift of arginine metabolism triggers systemic metabolic and immunological reprogramming to prevent HER2+ breast cancer
Vandana Sharma, Veani Fernando, Xunzhen Zheng, Eun Seok Choi, Osama Sweef, Venetia D. Thomas, Justin Szpendyk, Saori Furuta
This study shows that long-term SEP treatment prevents HER2+ breast cancer by reprogramming systemic metabolism and immunity, increasing memory T cell formation.
Cancer & Metabolism · Mar 20, 2025Peer-reviewedCancer Biology